Meet our Advisors

Professor of Surgery. Chief of Breast Surgery and Fellowship Director at Georgetown University Hospital in Washington D.C.

Dr. Eleni Tousimis, MD, is a renowned board-certified breast surgical oncologist with expertise in minimally invasive breast cancer surgery practicing at MedStar Georgetown University Hospital. She has over 15 years of experience in nipple-sparing mastectomy. She is known as a pioneer in this technique and teaches it nationally. She uses a bra-line incision whenever feasible, barely leaving a visible scar. Her attention to cancer cure, cosmetic outcome, and pain control during and after surgery has led to improved recovery, aesthetics, and outcomes for her patients. Other procedures she performs include bloodless breast surgery, breast biopsy, breast conservation, lumpectomy, and mastectomy.

Dr. Tousimis attended Dartmouth and Mount Holyoke College where she graduated cum laude. She then received her medical degree from Albany Medical College. Following her breast surgery fellowship training at Memorial Sloan Kettering Cancer Center in New York City, she completed additional specialty training in minimally invasive surgery of the breast at the European Institute of Oncology in Milan, Italy.

Dr. Tousimis was previously Associate Professor of Clinical Surgery at the Weill Cornell Medical College, New York-Presbyterian Hospital and served as Associate Program Director of Surgical Education. She has been recognized for her pursuit of new initiatives in breast cancer management, including nipple-sparing mastectomy, partial breast radiation, and new anesthetic techniques for breast surgery.

As a well-respected clinician, researcher, and teacher, Dr. Tousimis holds a variety of leadership positions in several professional societies. She was the 99th President of the American Medical Women’s Association and acted as Section Editor of the Aesthetic Plastic Surgery Journal. She has been recognized as one of Castle Connolly’s Top Doctors, Top Surgeons and Best Doctors in 2009-present. She has received numerous awards including an Achievement Award from the City of New York for her surgical skill, compassion, and service as well as the Kalopthakis Award, which recognizes the contributions of female physicians.

Cleveland Clinic Oncology Specialist

Dr. Montero is a Physician in the Department of Solid Tumor Oncology at Cleveland Clinic, specializing in breast cancer for the last 13 years.Prior to joining the Cleveland Clinic, Dr. Montero was breast cancer site disease co-leader at the University of Miami Sylvester Comprehensive Cancer Center.Throughout his medial career, he has led process improvements in oncology to develop effective and efficient treatment strategies in breast cancer achieving better clinical outcomes and a superior quality of care for patients.Dr. Montero clinical research interests have focused on immune-based therapies in breast cancer and other solid malignancies; a better understanding the various mechanisms by which tumors evade the immune system; and the improvement of clinical outcomes in patients with breast cancer through the development of novel targeted therapies.He has been the principal investigator in over 30 clinical trials, he has co-authored over 50 peer reviewed publications and several studies examining the cost-effectiveness of targeted therapies currently utilized for the treatment of metastatic breast cancer.Dr. Montero earned his Medical Degree from the University of Texas Medical Branch at Galveston. He completed his fellowship training in hematology/oncology at the University of Texas M.D. Anderson Cancer Center.He is a Six Sigma Green Belt.

Dr. Balcells-Camps is a Principal Research Scientist at MIT’s Institute for Medical Engineering and Science (2016) and Profesora Titular in Bioengineering at Institut Químic de Sarrià (2006) in Barcelona. Her research in tissue engineering has shown how endothelial cell states are critical to tissue response to injury, vascular and neurological; integrity of the endothelial monolayer and cross-talk with adjacent cells dictate vascular health and ability to withstand disease. She was the first to show that cells respond to flow frequency not just shear stress and in a manner which is tissue bed dependent. She demonstrated that endothelial cells from the heart and blood vessels, lungs or gastrointestinal tract proliferate optimally under flow conditions whose frequency is tuned to the operating frequency of their host tissue. She compared the response of macro- and microvascular endothelial cells to flow and to inflammation, and reported that microvasculature endothelial cells become more inflamed than their arterial counterparts when exposed to high shear stress suggesting an arterial/neurological disease link. Confluent endothelial cell monolayers withstand amyloid beta toxicity, while cells in subconfluent/injured state cannot. The concepts she has elaborated have already helped understand why microvascular disease is such an important element and exacerbent of neurologically dementing diseases. Dr. Balcells-Camps’ research bridges the cardiovascular and neuroscientific domains - closing the gap between computational predictions and animal models, through functional and signaling studies on endothelial and neighboring cells performed in a highly multidisciplinary fashion.

Through her dual appointment at MIT and Institut Quimic de Sarria, Dr. Balcells-Camps has promoted innovative, highly productive research and educative exchanges between both institutions and countries. As a direct consequence of her work in extending MIT’s international opportunities for students and faculty she created the International MIT-Spain Program. Each year the program provides 50 MIT students across schools and departments with internship opportunities in Spanish companies, universities and research centers. In 2011, Spain’s government bestowed Dr. Balcells-Camps with the Cross of the Order of the Civil Merit for her contribution to establish a fruitful channel between MIT and her home country, Spain. Dr. Balcells-Camps chairs MIT innovation program IDEA2 Global within MIT LinQ Initiative and directs the Global CoCreation Lab at MIT Institute for Medical Engineering and Science. For her service to MIT and to the world, Dr. Balcells-Camps has recently received the 2019 MIT Excellence Awards “Advancing inclusion and global perspectives: maximizing MIT's strengths”.

Dr. Balcells is a passionate basic scientist who embraces working with physicians and clinicians as well as industry partners to accelerate the path of new technologies and therapies from bench to bed-site. She is also a motivated mentor and the projects she leads become the ideal venue to educate the next generation of engineers, biologists, material scientists, physicians, computer scientists and chemists who learn to work collaborative as the only way to solve today’s greatest challenges in health.

Founder and CEO of HERHealthEQ

Marissa Fayer is a 19-year medtech executive, entrepreneur, and philanthropist. She is the CEO and founder of non-profit HERHealthEQ, the president of advisory firm Fayer Consulting LLC, and a partner at a direct investment firm. Her mission is to move innovation and the health of women forward throughout the world through the advancement of organizations and the communities in which they operate by increasing efficiency, building world-class organizations, and enhancing partnerships. Through the development of innovation and technology that enhance and better a woman’s life, she can more productively contribute to an equal society and change the lives of their families, their community, and their country within one generation.Marissa has previously served as an executive at Hologic, Olympus (formerly ACMI), Maquet-Getting (formerly Atrium Medical), Providien Medical, and Accumed Innovative Technologies. Additionally she has consulting for several of the Top 500 companies in the world and is a seasoned executive. Marissa graduated from Boston University with a BS in Manufacturing Engineering and from University of Connecticut with an MBA.Marissa has been listed as one of the Top 100 Women in Medtech in 2018, a Top Woman Activist to Watch, awarded the 2018/9 Africa Development Award, a Wonder Women in Medtech in 2017, and has spoken at the World Alliance Forum, the MPO Summit, DeviceTalks Boston, numerous non-profit dedication ceremonies, and for several Top 500 companies. Marissa has appeared in several online and print publications such as Medical Design & Outsourcing, Med Device Online, MPO magazine and TheStreet.com.

Plastic and Reconstructive Surgeon

Dr. Rosenberg has served the medical profession for more than five decades, earning outstanding credentials in his specialty as a Cosmetic and Complex Reconstructive Plastic Surgeon for the entire body.

A Diplomate of the American Board of Plastic Surgery since 1969, and in private practice since 1970, he has authored innovative publications in medical journals, including being the first plastic surgeon to publish the introduction of fiber optic retractors into the field of plastic surgery for use in surgery of the face, nose, and breast.

His medical experience covers pioneering achievements in renowned New York Hospitals - Mount Sinai, Beth Israel, and New York-Presbyterian. He served as a Commander in the United States Navy as Chief of Plastic Surgery at a major medical center during the Vietnam War, helping soldiers return to civilian life without the burden of disfigurement and disability. His has built long-term affiliations with these renowned hospitals. New York-Presbyterian has honored him by hanging his portrait for his many accomplishments.

He also served as the Director of Aesthetic Plastic Surgery at NYU Downtown Hospital for more than two decades.

Dr. Rosenberg has been recognized on the highest-rated media in the U.S., including but not limited to The New York Times, and Oprah Winfrey.

American Society of Aesthetic Plastic Surgery, American College of Surgeons, International College of Surgeons, Society of Military Plastic Surgeons.

Co-founder and President of Boarding for Breast Cancer (B4BC)

Lisa Hudson is co-founder and President of Boarding for Breast Cancer (B4BC) - a non-profit foundation dedicated to providing breast cancer education, prevention and support programs for young people and the action sports community at large. She has served on the B4BC’s Board of Directors from 1999 to present.

Lisa is also Lisa is President Black Sun Productions, a leading developer of action sports and lifestyle mobile applications and videogames. To date Black Sun has worked on over 29 video games including the Tony Hawk, Call of Duty and Guitar Hero Franchises along with numerous snowboard and surfing titles. In 2009, Black Sun expanded to include mobile app development and has created a robust media apps for brands like Metallica, Airstream, Vans, Zumiez, Rocket Dog Shoes, Absinthe Films, and Astro Gaming.

Lisa competed on the Women’s Pro Beach Volleyball (WPVA) Tour from 1985 – 1995, she served on the WPVA Board of Director’s from 1988 to 1993 and was Vice President from 1991-1993.

Lisa lives in Marin, CA with her husband Jack Rebbetoy and their son Shayne.

CEO of the Fastrack Institute & Former Chairman and CEO of One Laptop Per Child

Rodrigo is a senior executive with 40 years of experience in business development across the U.S. and LATAM.

His remarkable achievements include being responsible for the largest airport privatization project in the world for 33 airports in Argentina. He also started the largest flower export business in Colombia, later diversifying into the transportation and distribution industry for perishable goods and has served as a senior VP of business development for Ogden, in LATAM and Spain. He is currently a partner in Globis Group, a management consulting group serving industries in engineering, accounting and research in the U.S.

Rodrigo has been actively involved in philanthropic and humanitarian causes. He has served as the CEO of One laptop Per Child (OLPC), has been a Board Member of 2B1, a non-profit organization in consortium with MIT media labs, bringing education opportunities to third world countries.

Rodrigo has served as a visiting scholar of MIT Media Lab in LATAM and as a director in the development of E4P (Education for Peace) project.

Rodrigo holds a Bachelor’s Degree in Architecture from Massachusetts Institute of Technology and a Post Graduate Degree in Strategic Studies from Western Behavioral Science Institute (WBSI) La Jolla, California.

Managing Director Bank Sabadell

Maurici is an executive with extensive experience in the financial sector in Spain, LATAM, and the United States.

He has served the industry for over 28 years with a diverse perspective in international and domestic commercial banking, corporate banking, project finance, and international wealth management.

In his current role at Banco Sabadell, Maurici oversees offices in New York, Mexico, Dominican Republic, Colombia, Brazil, Singapore, China (Beijing, Shanghai), and India. He is accredited with building and expanding the corporate banking activity of the bank in the regions.

Maurici earned a degree in law from Universitat de Barcelona, Spain.

CEO and Founder of Care Angel

Wolf is a serial entrepreneur, creative technologist, healthcare futurist and experienced Chief Executive Officer with a demonstrated history of transformative technological innovations.

He is the Founder and CEO of CareAngel, the award-winning pioneering company that designed the world's first Virtual Health Assistant to meet the complex needs of people with chronic conditions.

Wolf also founded Consult a Doctor, an initiative that partnered with health plans, self-insured groups, TPA, brokers and various other groups to offer convenient 24/7 access to physicians for phone and secure email medical consultations. The company was acquired by Teladoc, a Kliener, Perkins portfolio company.

Wolf has been shaping and transforming the telehealth space since the earliest days of digital health, nearly 20 years ago.

He is recognized as a being a hands-on leader who is driven by passion in the pursuit of building impactful, enterprise platforms and consumer solutions targeted to help alleviate the most pressing challenges affecting the entire healthcare ecosystem.

Wolf earned a bachelor´s degree in finance and business administration from the University of South Florida.

Chair, CEO & Co-Founder of Conexus AI, Inc.

Eric worked in the Executive Office of the President during the Obama Administration where he helped drive the agenda for U.S. leadership in research, commercialization, and public adoption of AI & Robotics. Companies which he has led since The White House have worked to transform traditional industries with these modern digital technologies. He also sits on the board of Petuum, the largest AI investment by Softbank’s vision Fund. He has co-founded six technology companies with pioneering work in fields ranging from storage software systems to statistical arbitrage.

A frequent speaker, lecturer, and commentator, Eric works to empower communities and citizens to leverage robotics and AI to build a more sustainable, secure, and prosperous future. His academic research has been at the intersection of Machine Learning, Computational Linguistics, and Network Science (Graph Theory).

He has a specialization in computation and policy, including public policy and economics. He served as Assistant Professor and Assistant Dean at Carnegie Mellon’s School of Computer Science where he founded the university’s Entrepreneurial Management program and helped to launch Carnegie Mellon’s Silicon Valley Campus. He has studied at the University of Washington-Seattle, Stanford University, and Carnegie Mellon University, where he earned his PhD in Computer Science.